Showing results (1-10 of 513) with videos related to
Sort By:
Pageof 52
Clinical Nuclear Medicine|September 28, 2021
18F-Fluciclovine-Avid Pulmonary HamartomaSacha C Baldeosingh, Steven P Rowe, Stephen C Greco, et al.World Journal of Nuclear Medicine|January 15, 2020
Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted 18F-DCFPyL positron emission tomography/computed tomography: A unique visual patternYafu Yin, Channing J Paller, Martin G Pomper, et al.Drug Design, Development and Therapy|March 31, 2011
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancerChanning J Paller, Emmanuel S AntonarakisHuman Vaccines & Immunotherapeutics|February 17, 2012
Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challengesChanning J Paller, Emmanuel S AntonarakisClinical Advances in Hematology & Oncology : H&O|February 19, 2013
Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directionsChanning J Paller, Emmanuel S AntonarakisUrologic Oncology|January 10, 2025
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer managementNicole A Metri, Adel Mandl, Channing J PallerClinical Advances in Hematology & Oncology : H&O|July 6, 2016
Challenges of conducting clinical trials of natural products to combat cancerChanning J Paller, Samuel R Denmeade, Michael A CarducciClinical Interventions in Aging|October 11, 2012
Management of bone metastases in refractory prostate cancer--role of denosumabChanning J Paller, Michael A Carducci, George K PhilipsCells|January 11, 2024
Therapeutic Approaches to Targeting Androgen Receptor Splice VariantsViolet A Daniels, Jun Luo, Channing J Paller, et al.Seminars in Radiation Oncology|June 13, 2026
Integrative Oncology in Practice: Moving the SIO-ASCO Guidelines From Evidence to ImplementationNicole A Metri, Jasmin Hundal, Santosh Rao, et al.Pageof 52